Archaeologists studied hundreds of unfinished stone heads in a quarry on Easter Island to better understand how they were constructed and the society that made them.

(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ​signals in the "reward center" of the brain. These are the first direct measurements of brain activity ‌in a person receiving tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, shedding light on the treatment's impact on so-called ‌food noise.

A growing number of medical experts and officials are walking back shaken baby syndrome testimony that put parents behind bars. They face an uphill battle.